bioMerieux SA
(OTC: BMXXY)
|
6:09 PM UTC, 06/09/23 | |||
---|---|---|---|---|
Last: $9.51 | Change: -1.34 | %Change: -12.35% | Volume: 932 |
Open: | $ 9.51 | Volume: | 932 | |
---|---|---|---|---|
High: | $ 9.51 | Yield(%) | 0.52 | |
Low: | $ 9.51 | P/E Ratio (ttm): | 29.45 | |
Dividend ($): | 0.05 | Market Cap ($): | 11.39B | |
EPS ($) | n/a | Shares Out: | 1.18B |
% Price Change (last 4 weeks): | -7.78 |
---|---|
% Price Change (last 13 weeks): | -12.24 |
% Price Change (last 26 weeks): | -12.55 |
% Price Change (last 52 weeks): | -5.58 |
% Price Change (year to date): | -13.25 |
Return on Equity (%): | 9.68 |
---|---|
Return on Assets (%): | 6.82 |
Return on Invested Capital (%): | 13.29 |
Gross Profit Margin (%): | 54.87 |
---|---|
Net Profit Margin (%): | 9.73 |
Operating Profit Margin (%): | 14.58 |
|
|
50-day Moving Average: | $n/a |
---|---|
200-day Moving Average: | $n/a |
Avg. Daily Vol. (last 50 days): | n/a |
Avg. Daily Vol. (last 200 days): | n/a |
52-wk high: | $n/a |
52-wk low: | $n/a |
Bid: | $n/a |
Ask: | $n/a |
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
|
bioMerieux SA
376, chemin de l'Orme Marcy l'Etoile AR 69280 Phone: 33.4.78.87.20.00 Fax: 33.4.78.87.20.90 http://www.biomerieux.com |
Earnings (1year) ($): | 0.33 |
---|---|
Annual Dividend ($): | 0.05 |
Current P/E Ratio (ttm): | 29.45 |
Book Value ($): | 3.51 |
Cash Flow ($): | 0.56 |
Price/Earnings (x): | 29.45 |
---|---|
Price/Sales (x): | 3.32 |
Price/Book (x): | 3.17 |
Price/Cash Flow (x): | 27.42 |
Quick Ratio (x): | 1.16 |
---|---|
Current Ratio (x): | 2.03 |
LT Debt/Equity (x): | 9.47 |
Total Debt/Equity (x): | 13.83 |